Wellstat Therapeutics - Vistogard and Xuriden - Ownership and Business Overview

Life ScienceCompany

Wellstat Therapeutics - Vistogard and Xuriden Ownership

Who owns Wellstat Therapeutics - Vistogard and Xuriden?

Wellstat Therapeutics - Vistogard and Xuriden is owned by SERB S.a.r.l.. It was acquired on July 13, 2023.

Wellstat Therapeutics - Vistogard and Xuriden Business Overview

Where is Wellstat Therapeutics - Vistogard and Xuriden headquartered?

Wellstat Therapeutics - Vistogard and Xuriden is headquartered in Rockville, Maryland.

What sector is Wellstat Therapeutics - Vistogard and Xuriden in?

Wellstat Therapeutics - Vistogard and Xuriden is a life science company.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 196 acquisitions of life science companies in 2023, including 22 acquisitions by private equity firms, and 174 by strategics.

Wellstat Therapeutics - Vistogard and Xuriden

Wellstat Therapeutics - Vistogard and Xuriden

Rockville, Maryland 20850
United States,

Wellstat Therapeutics's Vistogard and Xuriden provides emergency treatment for adult and pediatric patients with hereditary orotic aciduria (HOA)[ii], an ultra-rare, orphan genetic disorder associated megaloblastic anemia as well as failure to thrive, developmental delay, epilepsy, susceptibility to infection, and orotic acid crystals in the urine.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.